306 related articles for article (PubMed ID: 15793110)
1. Development of a cell-based high-throughput specificity screen using a hepatitis C virus-bovine viral diarrhea virus dual replicon assay.
O'Boyle DR; Nower PT; Lemm JA; Valera L; Sun JH; Rigat K; Colonno R; Gao M
Antimicrob Agents Chemother; 2005 Apr; 49(4):1346-53. PubMed ID: 15793110
[TBL] [Abstract][Full Text] [Related]
2. Establishment of a subgenomic replicon for bovine viral diarrhea virus in Huh-7 cells and modulation of interferon-regulated factor 3-mediated antiviral response.
Horscroft N; Bellows D; Ansari I; Lai VC; Dempsey S; Liang D; Donis R; Zhong W; Hong Z
J Virol; 2005 Mar; 79(5):2788-96. PubMed ID: 15708997
[TBL] [Abstract][Full Text] [Related]
3. Development of a novel dicistronic reporter-selectable hepatitis C virus replicon suitable for high-throughput inhibitor screening.
Hao W; Herlihy KJ; Zhang NJ; Fuhrman SA; Doan C; Patick AK; Duggal R
Antimicrob Agents Chemother; 2007 Jan; 51(1):95-102. PubMed ID: 17060518
[TBL] [Abstract][Full Text] [Related]
4. Effect of antimetabolite immunosuppressants on Flaviviridae, including hepatitis C virus.
Stangl JR; Carroll KL; Illichmann M; Striker R
Transplantation; 2004 Feb; 77(4):562-7. PubMed ID: 15084936
[TBL] [Abstract][Full Text] [Related]
5. Bovine viral diarrhea virus as a surrogate model of hepatitis C virus for the evaluation of antiviral agents.
Buckwold VE; Beer BE; Donis RO
Antiviral Res; 2003 Sep; 60(1):1-15. PubMed ID: 14516916
[TBL] [Abstract][Full Text] [Related]
6. Generation and characterization of a hepatitis C virus NS3 protease-dependent bovine viral diarrhea virus.
Lai VC; Zhong W; Skelton A; Ingravallo P; Vassilev V; Donis RO; Hong Z; Lau JY
J Virol; 2000 Jul; 74(14):6339-47. PubMed ID: 10864644
[TBL] [Abstract][Full Text] [Related]
7. In vitro efficacy of approved and experimental antivirals against novel genotype 3 hepatitis C virus subgenomic replicons.
Yu M; Corsa AC; Xu S; Peng B; Gong R; Lee YJ; Chan K; Mo H; Delaney W; Cheng G
Antiviral Res; 2013 Nov; 100(2):439-45. PubMed ID: 24013001
[TBL] [Abstract][Full Text] [Related]
8. Development of a cell-based assay for high-throughput screening of inhibitors against HCV genotypes 1a and 1b in a single well.
Mondal R; Koev G; Pilot-Matias T; He Y; Ng T; Kati W; Molla A
Antiviral Res; 2009 Apr; 82(1):82-8. PubMed ID: 19174175
[TBL] [Abstract][Full Text] [Related]
9. Establishment of a robust hepatitis C virus replicon cell line over-expressing P-glycoprotein that facilitates analysis of P-gp drug transporter effects on inhibitor antiviral activity.
Hernandez D; Falk P; Yu F; Zhai G; Quan Y; Faria T; Cao K; Scola P; McPhee F
Biochem Pharmacol; 2013 Jan; 85(1):21-8. PubMed ID: 23063413
[TBL] [Abstract][Full Text] [Related]
10. Development of hepatitis C virus chimeric replicons for identifying broad spectrum NS3 protease inhibitors.
Binder J; Tetangco S; Weinshank M; Maegley K; Lingardo L; Diehl W; Love R; Patick AK; Smith GJ
Antiviral Res; 2011 Aug; 91(2):102-11. PubMed ID: 21620899
[TBL] [Abstract][Full Text] [Related]
11. A cell-based beta-lactamase reporter gene assay for the identification of inhibitors of hepatitis C virus replication.
Zuck P; Murray EM; Stec E; Grobler JA; Simon AJ; Strulovici B; Inglese J; Flores OA; Ferrer M
Anal Biochem; 2004 Nov; 334(2):344-55. PubMed ID: 15494142
[TBL] [Abstract][Full Text] [Related]
12. A cellular replicon-based phenotyping assay to determine susceptibility of hepatitis C virus clinical isolates to NS3/4A protease inhibitors.
Vijgen L; Verbeeck J; Van Kerckhove B; Berke JM; Koletzki D; Fanning G; Lenz O
Methods Mol Biol; 2013; 1030():105-17. PubMed ID: 23821263
[TBL] [Abstract][Full Text] [Related]
13. Anti-bovine viral diarrhoea virus and hepatitis C virus activity of the cyclooxygenase inhibitor SC-560.
Okamoto M; Sakai M; Goto Y; Salim MT; Baba C; Goto K; Watashi K; Shimotohno K; Baba M
Antivir Chem Chemother; 2009 Sep; 20(1):47-54. PubMed ID: 19794231
[TBL] [Abstract][Full Text] [Related]
14. A reporter-based assay for identifying hepatitis C virus inhibitors based on subgenomic replicon cells.
Lee JC; Chang CF; Chi YH; Hwang DR; Hsu JT
J Virol Methods; 2004 Mar; 116(1):27-33. PubMed ID: 14715304
[TBL] [Abstract][Full Text] [Related]
15. Development of cell-based assays for in vitro characterization of hepatitis C virus NS3/4A protease inhibitors.
Chung V; Carroll AR; Gray NM; Parry NR; Thommes PA; Viner KC; D'Souza EA
Antimicrob Agents Chemother; 2005 Apr; 49(4):1381-90. PubMed ID: 15793116
[TBL] [Abstract][Full Text] [Related]
16. [Study of the antiviral mechanism of action of ribavirin in the bovine viral diarrhea virus model].
Escuret V; Parvaz P; Hantz O; Petit MA; Trepo C; Zoulim F
Gastroenterol Clin Biol; 2002; 26(6-7):584-90. PubMed ID: 12193857
[TBL] [Abstract][Full Text] [Related]
17. In silico identification, design and synthesis of novel piperazine-based antiviral agents targeting the hepatitis C virus helicase.
Bassetto M; Leyssen P; Neyts J; Yerukhimovich MM; Frick DN; Courtney-Smith M; Brancale A
Eur J Med Chem; 2017 Jan; 125():1115-1131. PubMed ID: 27810598
[TBL] [Abstract][Full Text] [Related]
18. High-throughput screening of HCV RNA replication inhibitors by means of a reporter replicon system.
Hao W; Duggal R
Methods Mol Biol; 2009; 510():243-50. PubMed ID: 19009266
[TBL] [Abstract][Full Text] [Related]
19. [Replication of the subgenomic hepatitis C virus replicon in the presence of the NS3 protease inhibitors: a stochastic model].
Ivanisenko NV; Mishchenko EL; Akberdin IR; Demenkov PS; Likhoshvai VA; Kozlov KN; Todorov DI; Samsonova MG; Samsonov AM; Kolchanov NA; Ivanisenko VA
Biofizika; 2013; 58(5):758-74. PubMed ID: 25481944
[TBL] [Abstract][Full Text] [Related]
20. What is known about the antiviral agents active against bovine viral diarrhea virus (BVDV)?
Finkielsztein LM; Moltrasio GY; Caputto ME; Castro EF; Cavallaro LV; Moglioni AG
Curr Med Chem; 2010; 17(26):2933-55. PubMed ID: 20858174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
